Patents by Inventor Raluca Andreia Predoiu

Raluca Andreia Predoiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST
    Publication number: 20240247065
    Abstract: The present disclosure describes methods of treatment of cancer in patients with altered activity or amount of a SETD2 biomarker with a treatment regimen comprising an antagonist of Programmed Death 1 receptor (PD-1).
    Type: Application
    Filed: May 16, 2022
    Publication date: July 25, 2024
    Applicant: MERCK SHARP & DOHME LLC
    Inventors: Razvan CRISTESCU, Elisha DETTMAN, Yongjin LI, Karla Gabriela RODRIGUEZ-LOPEZ, Michael NEBOZHYN, Rodolfo Fleury PERINI, Raluca Andreia PREDOIU, Yiwei ZHANG
  • DOSING REGIMEN OF ANTI-TIGIT ANTIBODY FOR TREATMENT OF CANCER
    Publication number: 20210403557
    Abstract: The present invention relates to dosing regimens of an anti-TIGIT antibody useful for the treatment of cancer. In particular, the invention relates to the dosing regimen in a combination therapy which comprises administering an antibody of a Programmed Death 1 protein (PD-1) or Programmed Death Ligand 1 (PD-L1) and an anti-TIGIT antibody.
    Type: Application
    Filed: November 4, 2019
    Publication date: December 30, 2021
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Mingmei Cai, Elliot K. Chartash, Jane Anne Healy, Mallika Lala, Tommy Ruosi Li, Kapil Mayawala, Raluca Andreia Predoiu, Sybil M.G. Williams, Zhen Zeng